Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Redox's Marketable Securities for the quarter that ended in Dec. 2025 was €0.0 Mil.
Redox's annual Marketable Securities
increased
from Jun. 2023 (€0.0 Mil) to Jun. 2024 (€75.6 Mil) but then
declined
from Jun. 2024 (€75.6 Mil) to Jun. 2025 (€45.7 Mil).
Redox (FRA:AE0) Marketable Securities Explanation
Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.
Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".
Redox Marketable Securities Related Terms
Redox Marketable Securities Historical Data
* Premium members only.
The historical data trend for Redox's Marketable Securities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Marketable Securities of €0.0 Mil mean?
Redox (FRA:AE0) has a Marketable Securities of €0.0 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Redox and its competitors.
Is Redox's Marketable Securities too high?
Redox's current Marketable Securities is €0.0 Mil. Overall, Redox has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Redox's Marketable Securities compare to DOW?
Redox's Marketable Securities of €0.0 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Chemicals company?
A good Marketable Securities depends on the Chemicals industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Redox and its competitors. Redox's current Marketable Securities is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Redox stock overvalued right now?
Redox (FRA:AE0) has a current Marketable Securities of €0.0 Mil. The stock's GF Value™ is €1.83, compared to a current price of €2.24 — trading 22.4% above its estimated fair value. The current Marketable Securities is €0.0 Mil. Redox's overall GF Score™ is 72/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Redox (FRA:AE0), the current Marketable Securities is €0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Redox (FRA:AE0) Overvalued in 2026?
Based on GuruFocus' analysis, Redox stock appears to be overvalued.
The current stock price of €2.24 is trading 22.4% above its estimated GF Value™ of €1.83.
Key valuation signals for FRA:AE0:
Marketable Securities: €0.0 Mil
GF Value™: €1.83 vs. price of €2.24 (22.4% above fair value)
No single metric tells the full story. See the FRA:AE0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Redox is a distributor of chemicals for a diverse range of industries within Australia and New Zealand, North America, and Southeast Asia. It is the largest player in the Australian market, with approximately 5% market share in a very fragmented market. In Southeast Asia and the US it is a smaller player, but with growth ambitions. Redox sources over 5,000 stock keeping units from about 1,000 domestic and global chemical producers. Its customers are from a diverse range of more than 200 industry subsectors. About half of annual sales are in the categories of human and animal health, nutrition, food, and crop production and protection. Other categories include industrial, surface coatings, plastics, rubber and foam, household and personal care, water care, and mining and explosives.
72GF Score
Get the complete analysis for FRA:AE0
Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:AE0 has been successfully added to your 
